Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Other Non-Current Liabilities (2020 - 2021)

Lexaria Bioscience's Other Non-Current Liabilities history spans 2 years, with the latest figure at $49989.0 for Q3 2021.

  • For Q3 2021, Other Non-Current Liabilities fell 44.08% year-over-year to $49989.0; the TTM value through Aug 2021 reached $49989.0, down 44.08%, while the annual FY2021 figure was $49989.0, 44.08% down from the prior year.
  • Other Non-Current Liabilities for Q3 2021 was $49989.0 at Lexaria Bioscience, down from $89393.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $89393.0 in Q3 2020 and bottomed at $49989.0 in Q3 2021.